KOCAA
Knights of Columbus Asset Advisors’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
19,912
+3,932
| +25% | +$410K | 0.13% | 178 |
|
|
2025
Q1 | $1.86M | Sell |
15,980
-4,957
| -24% | -$578K | 0.13% | 176 |
|
|
2024
Q4 | $1.77M | Buy |
20,937
+52
| +0.2% | +$4.4K | 0.12% | 202 |
|
|
2024
Q3 | $1.88M | Sell |
20,885
-11,625
| -36% | -$1.04M | 0.12% | 192 |
|
|
2024
Q2 | $2.62M | Buy |
32,510
+9,957
| +44% | +$802K | 0.17% | 183 |
|
|
2024
Q1 | $1.8M | Buy |
+22,553
| New | +$1.8M | 0.13% | 207 |
|
|
2021
Q3 | – | Sell |
-22,142
| Closed | -$1.49M | – | 306 |
|
|
2021
Q2 | $1.49M | Buy |
22,142
+4,054
| +22% | +$274K | 0.14% | 217 |
|
|
2021
Q1 | $1.02M | Sell |
18,088
-220
| -1% | -$12.5K | 0.1% | 242 |
|
|
2020
Q4 | $1.49M | Buy |
18,308
+3,352
| +22% | +$273K | 0.16% | 228 |
|
|
2020
Q3 | $1.07M | Sell |
14,956
-2,211
| -13% | -$158K | 0.13% | 234 |
|
|
2020
Q2 | $1.41M | Buy |
17,167
+2,023
| +13% | +$167K | 0.17% | 188 |
|
|
2020
Q1 | $891K | Buy |
+15,144
| New | +$891K | 0.11% | 258 |
|